CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival

[1]  R. McLendon,et al.  EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma , 2009, Brain pathology.

[2]  A. Friedman,et al.  An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme , 2009, Molecular Cancer Therapeutics.

[3]  A. Heimberger,et al.  The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients , 2009, Expert opinion on biological therapy.

[4]  D. Bigner,et al.  Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function , 2007, Clinical Cancer Research.

[5]  Shimon Sakaguchi,et al.  Natural regulatory T cells: mechanisms of suppression. , 2007, Trends in molecular medicine.

[6]  H. Ohtani.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. , 2007 .

[7]  P. Mischel,et al.  Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma , 2007, Nature Medicine.

[8]  H. Ohtani,et al.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. , 2007, Cancer immunity.

[9]  W. Curry,et al.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. , 2007, Cancer immunity.

[10]  H. Dressman,et al.  Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers , 2006, Clinical Cancer Research.

[11]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[12]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.

[13]  M. Lesniak,et al.  An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. , 2006, Neuro-oncology.

[14]  K. Aldape,et al.  Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. , 2006, Neuro-oncology.

[15]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[16]  Gerd Ritter,et al.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Black,et al.  T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches. , 2005, Frontiers in bioscience : a journal and virtual library.

[18]  Timothy F. Cloughesy,et al.  Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment , 2005, Clinical Cancer Research.

[19]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[20]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[21]  L. Liau,et al.  Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. , 2004, Journal of neurosurgery.

[22]  M. Esiri,et al.  The mononuclear cell infiltrate compared with survival in high-grade astrocytomas , 2004, Acta Neuropathologica.

[23]  L. Liau,et al.  Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. , 2003, Cancer research.

[24]  L. Liau,et al.  PRIMER IN MOLECULAR MEDICINE , 2003 .

[25]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[26]  H. Fine,et al.  History of allergies and autoimmune diseases and risk of brain tumors in adults , 2002, International journal of cancer.

[27]  R. Miike,et al.  History of allergies among adults with glioma and controls , 2002, International journal of cancer.

[28]  B. O'neill,et al.  Gliomas arising in organ transplant recipients: An unrecognized complication of transplantation? , 2001, Neurology.

[29]  W Feiden,et al.  PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme , 2001, Oncogene.

[30]  A. Belldegrun,et al.  Treatment of a glioblastoma patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides , 2000 .

[31]  A. Belldegrun,et al.  Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. , 2000, Neurosurgical focus.

[32]  E. Perkins,et al.  Long-term remission of malignant brain tumors after intracranial infection: a report of four cases. , 1999, Neurosurgery.

[33]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.

[34]  R Miike,et al.  Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.

[35]  B. Jasani,et al.  A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection. , 1996, The Journal of infection.

[36]  Natale Cascinelli,et al.  Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.

[37]  M. Mihm,et al.  Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[38]  A. d’Arminio Monforte,et al.  Cerebral astrocytoma in HIV-infected patients. , 1995, AIDS.

[39]  A. Moulignier,et al.  Cerebral glial tumors and human immunodeficiency virus‐ 1 infection: More than a coincidental association , 1994, Cancer.

[40]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[41]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[42]  J. Villemure,et al.  Characterization of lymphoid cells isolated from human gliomas. , 1989, Journal of neurosurgery.

[43]  H. Abe,et al.  Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2. , 1989, Cancer research.

[44]  M. Hamou,et al.  Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. , 1988, Cancer research.

[45]  C. Morris,et al.  Mononuclear cell infiltration in central portions of human astrocytomas. , 1988, Journal of neurosurgery.

[46]  W. Roggendorf,et al.  Inflammatory infiltrates and natural killer cell presence in human brain tumors , 1988, Cancer.

[47]  F. Hochberg,et al.  Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. , 1985, Surgical neurology.

[48]  D. Böker,et al.  Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. , 1984, Clinical neuropathology.

[49]  M. Apuzzo,et al.  Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. , 1984, Journal of neurosurgery.

[50]  A. Piazza,et al.  Analysis of Some Factors Effecting Survival in Malignant Gliomas , 1979, Tumori.

[51]  N. Di Lorenzo,et al.  Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. , 1978, Journal of neurosurgery.

[52]  W. Markesbery,et al.  Relationship of lymphocyte invasion and survival of brain tumor patients , 1978, Annals of neurology.

[53]  R. Barnard,et al.  Perivascular lymphocytic cuffing in astrocytomas. , 1976, Acta neuropathologica.

[54]  J. Cavanagh,et al.  Lymphocytic infiltration in gliomas: evidence of possible host resistance. , 1971, Brain : a journal of neurology.